This is notable in that the majority of anti-TGFβ activity may be to suppress tumor growth and metastases through its effects on epithelial-to-mesenchymal transition, immune response and tumor microenvironment, rather than an ability to directly kill tumor cells. Here, TGFB1 is linked to neoplasm.